SR-9009 Uses, Dosage, Side Effects and more
SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues .
| Trade Name | SR-9009 |
| Generic | SR-9009 |
| Type | |
| Formula | C20H24ClN3O4S |
| Weight | Average: 437.94 Monoisotopic: 437.1176051 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
